| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/06/2011 | US8013134 Kit for proximity probing with multivalent proximity probes |
| 09/06/2011 | US8013126 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer |
| 09/06/2011 | US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines |
| 09/06/2011 | US8013114 Fusion proteins based upon somatostatin receptors |
| 09/06/2011 | US8013113 FRET protease assays for clostridial toxins |
| 09/06/2011 | US8012950 Using tartrate-resistant acid phosphatase activity as diagnostic indicator of degenerative ligament disease; bioassay |
| 09/06/2011 | US8012947 Methods and compositions for promoting wound healing |
| 09/06/2011 | US8012945 Single chain fragment variable (scFv) antibody or an Fab antibody; screening phage-displayed antibodies for an ability to bind to a radiation-inducible neoantigen present on a cell |
| 09/06/2011 | US8012930 Methods of treating pervasive development disorders |
| 09/06/2011 | US8012756 Charge perturbation detection system for DNA and other molecules |
| 09/06/2011 | US8012748 Peripheral nervous system specific sodium channel nucleic acids |
| 09/06/2011 | US8012747 Recombinant vesicular stomatitis viral vector system for delivery of interfering RNA sequences to cells; gene expression inhibition |
| 09/06/2011 | US8012745 Assay cartridges and methods of using the same |
| 09/06/2011 | US8012743 Detection of target analytes using particles and electrodes |
| 09/06/2011 | US8012740 Systems for genome selection |
| 09/06/2011 | US8012739 Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA synthetase pairs |
| 09/06/2011 | US8012731 Phosphodiesterase and gene thereof |
| 09/06/2011 | US8012729 Mutant glucose dehydrogenase |
| 09/06/2011 | US8012725 Method for the production of optically-active alcohols |
| 09/06/2011 | US8012720 Protein detecting device |
| 09/06/2011 | US8012711 Methods of screening for compounds that reduce microbial resistance to fluoroquinolones |
| 09/06/2011 | US8012710 Methods of treating and diagnosing Parkinsons disease and related dysautonomic disorders |
| 09/06/2011 | US8012709 Method for determining if a subject having type II diabetes has a kidney disorder |
| 09/06/2011 | US8012708 Method for determination of allergen in environment and kit for simple quantification of allergen |
| 09/06/2011 | US8012703 Microarrays and uses therefor |
| 09/06/2011 | US8012693 Analysis of chemically crosslinked cellular samples |
| 09/06/2011 | US8012692 Elastin peptide fingerprints and analysis methods for MMP12 related to COPD |
| 09/06/2011 | US8012691 Multiplex compositions and methods for quantification of human nuclear DNA and human male DNA and detection of PCR inhibitors |
| 09/06/2011 | US8012690 Enriching for sequestered populations of amplified nucleic acid molecules; immobilizing preferential nucleotide sequences onto beads, replicating sequences, recovering propagated nucleotide sequences |
| 09/06/2011 | US8012689 Elite event A2407-12 and methods and kits for identifying such event in biological samples |
| 09/06/2011 | US8012688 Gene expression profiling from FFPE samples |
| 09/06/2011 | US8012687 Isolated genomic polynucleotide fragments from chromosome 19 that encode human resistin and the human syntaxin binding protein 2 |
| 09/06/2011 | US8012686 Risk assessment for adverse drug reactions |
| 09/06/2011 | US8012685 Detection of analytes and nucleic acids |
| 09/06/2011 | US8012684 Mutated AQP, method for detecting cancer using the same, DNA chip having oligonucleotides of said mutated AQP sequence |
| 09/06/2011 | US8012683 Using polymorphic variation in complement cascade genes as evaluative tool in prognosis/diagnosis of vision defects |
| 09/06/2011 | US8012682 Nucleic acids encoding chromophores/fluorophores and methods for using the same |
| 09/06/2011 | US8012681 co-culturing cancer cells and host cells for a time sufficient to detect evidence of gene expression in co-culture for simulating the progression from a primary tumor to a metastasis in an in vitro model; anti-EphA2 ( epithelial cell kinase) antibody |
| 09/06/2011 | US8012680 Microchip, nucleic acid extracting kit, and nucleic acid extracting method |
| 09/06/2011 | US8012679 Papillomavirus vaccines |
| 09/06/2011 | US8012678 Biomarkers for human papilloma virus-associated cancer |
| 09/06/2011 | US8012492 In vitro model of latent mycobacterial infection |
| 09/06/2011 | US8012489 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers |
| 09/06/2011 | US8012419 Temperature-controlled incubator having rotatable door |
| 09/06/2011 | US8012341 Biosensor electrode mediators for regeneration of cofactors |
| 09/06/2011 | CA2678141C Collection device comprising penetrable cap and method for use thereof |
| 09/06/2011 | CA2654733C Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 09/06/2011 | CA2452260C Novel variants and exons of the glyt1 transporter |
| 09/06/2011 | CA2335230C Regions of papilloma virus e1 helicase involved in e1 oligomerization |
| 09/01/2011 | WO2011106770A2 Modified proteins and methods of making and using same |
| 09/01/2011 | WO2011106766A2 Modified proteins and methods of making and using same |
| 09/01/2011 | WO2011106738A2 Use of tcr clonotypes as biomarkers for disease |
| 09/01/2011 | WO2011106724A2 Fast pcr for str genotyping |
| 09/01/2011 | WO2011106709A2 Epithelial biomarkers for cancer prognosis |
| 09/01/2011 | WO2011106676A2 Methods of human embryonic stem cell growth |
| 09/01/2011 | WO2011106671A1 Assay for telomerase activity |
| 09/01/2011 | WO2011106634A2 Modified proteins and methods of making and using same |
| 09/01/2011 | WO2011106629A2 Modified proteins and methods of making and using same |
| 09/01/2011 | WO2011106558A1 Methods for autoimmune disease diagnosis, prognosis, and treatment |
| 09/01/2011 | WO2011106556A2 Systems and methods for adaptive recursive sequencing |
| 09/01/2011 | WO2011106549A2 Methods for determining gene-nutrient interactions |
| 09/01/2011 | WO2011106541A2 Diagnostic methods involving loss of heterozygosity |
| 09/01/2011 | WO2011106536A2 Methods of diagnosing infectious disease pathogens and their drug sensitivity |
| 09/01/2011 | WO2011106495A1 Cytogenic analysis of metaphase chromosomes |
| 09/01/2011 | WO2011106460A2 Methods for flip-strand immobilizing and sequencing nucleic acids |
| 09/01/2011 | WO2011106459A2 Analyte sequencing with nanopores |
| 09/01/2011 | WO2011106456A2 Artificial mycolic acid membranes |
| 09/01/2011 | WO2011106451A1 Methods of treating metal oxide surfaces and surfaces produced thereby |
| 09/01/2011 | WO2011106439A1 Signatures for kidney aging |
| 09/01/2011 | WO2011106401A2 Methods and compositions relating to multiciliate cell differentiation |
| 09/01/2011 | WO2011106373A2 Arnt isoform 3 as a predictor of aminoflavone responsiveness in cancer cells |
| 09/01/2011 | WO2011106368A2 Amplification methods to minimise sequence specific bias |
| 09/01/2011 | WO2011106363A2 Metabolic rate indicator for cellular populations |
| 09/01/2011 | WO2011106356A2 Diagnositic methods of tumor suspceptibility with single nucleotide polymorphisms inside microrna target sites |
| 09/01/2011 | WO2011106322A2 Biomarkers for acute ischemic stroke |
| 09/01/2011 | WO2011106314A2 Method of making nucleic acid libraries |
| 09/01/2011 | WO2011106310A1 Markers for obesity and methods of use thereof |
| 09/01/2011 | WO2011106255A1 Fluidic devices having incorporated electrodes |
| 09/01/2011 | WO2011106198A1 Methods for the detection of biologically relevant molecules and their interaction characteristics |
| 09/01/2011 | WO2011106104A2 Methods and compositions for the detection and treatment of cancer involving mirnas and mirna inhibitors and targets |
| 09/01/2011 | WO2011106083A1 Multiplex amplification reaction method for determination of campylobacter jejuni penner/capsule type |
| 09/01/2011 | WO2011106044A1 Device for and method of extracting a fraction from a biological sample |
| 09/01/2011 | WO2011105826A2 Method using camp expression measurement to diagnose prostate inflammation, and diagnostic kit |
| 09/01/2011 | WO2011105732A2 Method and kit for detecting egfr mutation by using pna-based real-time pcr clamping |
| 09/01/2011 | WO2011105667A1 Query sequence genotype or subtype classification method |
| 09/01/2011 | WO2011105654A1 Y-probe and variation thereof, and dna microarray, kit, and gene analysis method using the y-probe and the variation thereof |
| 09/01/2011 | WO2011105627A1 Firefly luciferase |
| 09/01/2011 | WO2011105573A1 Anti-icam3 antibody and use thereof |
| 09/01/2011 | WO2011105570A1 Method for determining presence or absence of cancer cell in biological sample, and molecular marker and kit for determination |
| 09/01/2011 | WO2011105556A1 Marker for detection of myogenic diseases, and method for detection of the diseases using same |
| 09/01/2011 | WO2011105551A1 Method for detection of cancer stem cell, and therapeutic agent or recurrence-preventing agent for cancer |
| 09/01/2011 | WO2011105335A1 Method for constructing novel bacterium belonging to the genus bifidobacterium |
| 09/01/2011 | WO2011105071A1 Method for screening nucleic acid ligand |
| 09/01/2011 | WO2011104770A1 Detection apparatus and method for detecting airborne biological particles |
| 09/01/2011 | WO2011104758A1 Method for amplifying target sequence within double-stranded dna |
| 09/01/2011 | WO2011104731A1 Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment |
| 09/01/2011 | WO2011104730A1 Genetic variants predictive of lung cancer risk |
| 09/01/2011 | WO2011104695A2 Detection of kras mutation in exon 2 by allele specific real time quantitative pcr (as-qpcr) |
| 09/01/2011 | WO2011104694A2 Detection of braf v600e mutation by allele specific real time quantitative pcr (as-qpcr) using locked nucleic acids primers and beacon probes |
| 09/01/2011 | WO2011104408A1 Method for prognosticating stroke |